COVID-19 vaccine candidates from Moderna and Pfizer both promising
Pfizer and Moderna have both announced promising results in the phase 3 trials of their COVID-19 vaccines. Here's how they differ.
COVID-19 vaccine candidates from Moderna and Pfizer both promising
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Moderna asking US, European regulators to OK its virus shots
SeattlePI.com
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study..
-
Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna
Motley Fool
-
UK stocks up on vaccines, hopes to start virus shots in days
SeattlePI.com
-
Canada not at back of line for COVID-19 vaccine, Moderna chairman says
CBC.ca
-
What connection does Moderna’s vaccine have to aborted fetal tissue?
CNA
Advertisement
More coverage
What If Multiple COVID-19 Vaccines Are Approved?
Newsy
Watch VideoAs COVID-19 spreads across much of the US, there’s a sign of hope: a third promising vaccine. AstraZeneca and the..
-
There are now three promising COVID vaccine candidates. This is what we know about them.
Delawareonline
-
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
What This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19
Motley Fool